References
- Aleman, B. M. P., van den Belt-Dusebout, A. W., Klokman, W. J., van't Veer, M. B., Bartelink, H., van Leeuwen, F. E. (2003). Long-term cause-specific mortality of patients treated for Hodgkin's disease. J. Clin. Oncology 21:3431–3439.
- Conklin, K. A. (2000). Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr. Cancer 37:1–18.
- Cornelli, U., Terranova, R., Luca, S., Cornelli, M., Alberti, A. (2001). Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J. Nutrition 131:3208–3211.
- Kagan, V. E., Gleiss, B., Tyurina, Y. Y. , et al. (2002). The role for oxidative stress in apoptosis: Oxidation and externalization of phosphatidylserine is required for macrophages clearance of cells undergoing Fas-mediated apoptosis. J. Immunol. 169:487–499.
- Mantovani, G., Macciò, A., Madeddu, C., Mura, L., Massa, E., Gramignano, G., Lusso, M. R., Murgia, V., Camboni, P., Ferreli, L. (2002). Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment. J. Cell. Mol. Med. 4:570–582.
- Martingale, J. L. , et al. (2002). Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192:1–15.
- Myers, C. (1998). The role of iron in Doxorubicyn-induced cardiomyopathy. Semin. Oncol. 25:10–14.
- Pascale, C., Formengo, P., Epifani, G., Bosio, F., Giacometto, F. (2002). Cardioprotection of trimetazidine and anthracycline-induced acute cardiotoxic effects. Lancet 359:1153–1154.
- Prasad, K. N. (2004). Multiple dietary antioxidants enhances the efficacy of standard and experimental cancer therapies and decrease their toxicity. Integrative Cancer Ther. 3:310–322.
- Raggi, F., Vallesi, G., Ruffini, F. , et al. Medical care with “SEQEX®” apparatus balances the oxidative scale in healthy volunteers: a clinical investigation of medical device. (In press).
- Savarese, D. M., Savy, G., Vahdat, L. , et al. (2003). Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat. Rev. 29:501–513.
- Shacter, E., Williams, J. A., Hinson, R. M., Senturker, S., Lee, Y. (2000). Oxidative stress interferes with cancer chemotherapy: inibition of lymphoma cell apoptosis and phagocytosis. Blood 96:307–313.
- Sparano, J. A. (1998). Use of Dexrazoxane and other strategies to prevent cardiomyopathy associated with doxorubicin-taxane combinations. Sem. Oncol. 25:66–71.